We are live on ! Find out more
KALV

KalVista Pharmaceuticals
KALV

Delisted

KALV was delisted on the 10th of June, 2026.

Back to rankings

41 hedge funds and large institutions have $84.1M invested in KalVista Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$19.9M
3
Franklin Resources
Franklin Resources
California
+$10.8M
4
BC
Broadfin Capital
New York
+$8.36M
5
PI
Putnam Investments
Massachusetts
+$4.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$60K +$59.2K +597 New
NFA
27
Nationwide Fund Advisors
Ohio
$56K +$55.6K +560 New
AIG
28
American International Group
New York
$51.4K +$51K +514 New
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$41K +$40.2K +405 New
Morgan Stanley
30
Morgan Stanley
New York
$38K +$38.1K +384 New
Citadel Advisors
31
Citadel Advisors
Florida
$28K +$27.7K +279 New
SO
32
STRS Ohio
Ohio
$27K +$27.7K +279 New
Deutsche Bank
33
Deutsche Bank
Germany
$23K +$23K +232 New
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$6K +$5.85K +59 New
RFC
35
Russell Frank Company
Washington
$5K +$4.96K +50 New
Invesco
36
Invesco
Georgia
$5K +$5.36K +54 New
Wells Fargo
37
Wells Fargo
California
$4K +$4.37K +44 New
Barclays
38
Barclays
United Kingdom
$2K +$1.69K +17 New
Bank of America
39
Bank of America
North Carolina
$2K +$2.38K +24 New
Citigroup
40
Citigroup
New York
$1K +$1.09K +11 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8 +$7.94K +80 New
1
2

KALV Hedge Fund Activity: Q2 2015 in Review

41 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in KalVista Pharmaceuticals (KALV) for Q2 2015, worth a combined $84.1M.

Buyers outnumbered sellers: 41 funds opened new KALV positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $23.4M.

  • 41 institutional investors held KalVista Pharmaceuticals (KALV) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $84.1M of KalVista Pharmaceuticals stock for Q2 2015.
  • 41 funds opened new KalVista Pharmaceuticals positions in Q2 2015 and 0 closed out, a net change of +41 holders.
  • The largest KalVista Pharmaceuticals buyer in Q2 2015 was Fidelity Investments, an estimated $23.4M added.

Based on aggregated 13F filings for Q2 2015.